In a new interview with Vulture, Sufjan Stevens opened up about his health following his 2023 diagnosis with Guillain-Barré ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...

The Task Force of the European Academy of Neurology and the Peripheral Nerve Society published updated guidelines in 2024 on the diagnosis and treatment of Guillain-Barré syndrome (GBS), which ...

and that there is a clear and urgent need for new and faster treatment options in GBS. This data offers meaningful insights to help advance the understanding of IgG in GBS and improve patient care." ...

A rare autoimmune disorder that affects the peripheral nervous system, not only does GBS appear suddenly, its residual symptoms can last for years, if not decades. Even after 20 years, some 42% of ...

Pune: A seven-and-half-year-old boy was discharged from Deenanath Mangeshkar Hospital on May 3 after battling a ...

Common symptoms include weakness ... "Most people who have GBS learn to walk again on their own within a year, so I am hopeful. I’m only in my second week of rehab but it is going really ...